Overview
- Rocket Lab shares pushed to new highs as traders leaned into the planned first Neutron launch later this year.
- First‑quarter revenue reached $200.35 million, up 63.5% year over year, with second‑quarter guidance at $225 million to $240 million and an expected adjusted EBITDA loss of $20 million to $26 million.
- Bookings accelerated with 31 new Electron and HASTE missions plus five Neutron contracts, lifting the total backlog to about $2.2 billion.
- The company highlighted its largest launch agreement to date, which includes five dedicated Neutron missions running through 2029.
- New defense work includes a Space Based Interceptor demonstration with Raytheon and a $30 million Anduril deal for hypersonic tests, while the stock screens overbought (RSI near 76), leaving sentiment vulnerable to any Neutron delays.